Quality & Compliance
Our quality framework is not a post-production layer. Every protocol — from seed selection to shipment documentation — is designed around the standards pharmaceutical buyers require before they place a purchase order.
NACOC
kg Annual Pilot Capacity
GACP
Global Market by 2030
ALCOA+
Prior Licensed Suppliers
in West Africa
EU-GMP
Prior Licensed Suppliers
in West Africa
Core Credentials
First-mover positioning under a purpose-built regulatory framework, backed by scientific infrastructure and a team built for pharmaceutical markets.
Active — February 2026
NACOC Licence — LI 2475
Hemp Medicinal Farm Ltd holds a licence under Ghana’s Narcotic Control Commission Act 1100 and Licensing Instrument LI 2475, the first formal pharmaceutical cannabis regulatory framework in West Africa, activated February 2026. This positions HMF Ltd as one of a small number of legal pharmaceutical cannabis producers on the continent.
Phase 1 Active
GACP Framework
Good Agricultural and Collection Practices implementation covering all cultivation, harvesting, and post-harvest handling operations.
— Controlled environment agriculture protocols
— Standardised cultivation SOPs
— Documented quality control at every stage requirements met
— Full seed-to-harvest traceability
— Personnel training and qualification records
ISO 17025-Adjacent
Analytical Laboratory
In-development analytical testing capabilities with current third-party testing partnerships for full batch verification.
— Cannabinoid profile analysis (HPLC validated)
— Terpene quantification
— Heavy metals — ICH Q3D / EU MRL compliant
— Microbial contamination per USP/Ph. Eur.
— Pesticide residue analysis
In Development
QMS Framework
Pharmaceutical-grade Quality Management System covering document control, deviation management, CAPA, change control, customer complaints, and full equipment and process validation.
— Document control and version management
— Deviation and non-conformance reporting
— Corrective and Preventive Action (CAPA) system
— Validation and qualification of equipment, tools, processes, and rooms (IQ/OQ/PQ)
— Internal audit programme
Our Approach
From the first cultivation decision to the final shipment document, every step at HMF Ltd is designed around the raw material requirements of regulated pharmaceutical supply chains.
Testing Protocols
Every batch of pharmaceutical-grade dried flower undergoes comprehensive testing. Results are included in the full documentation package provided with each shipment.
Cannabinoid Profile
THC Content
< 0.2% (EU Compliant Strains)
THC (High-THC strains)
15–28%
CBD Content
0.5–15% (strain dependent)
Minor Cannabinoids
CBG, CBC, CBN
Total Cannabinoids
15–20%
Method
HPLC (Ph. Eur. validated)
Terpene Analysis
Myrcene
Quantified per batch
Limonene
Quantified per batch
Pinene
Quantified per batch
Linalool
Quantified per batch
Total Terpenes
1–3%
Method
GC-FID / GC-MS
Contaminant Screening
Heavy Metals
Below EU MRLs / ICH Q3D
Pesticide Residues
Below EU MRLs
Microbial Load
< 1,000 CFU/g
Aflatoxins
< 4 ppb
Residual Solvents
< 5,000 ppm (Ph. Eur.)
Water Activity
≤ 0.65 Aw
Physical Specifications
Moisture Content
< 12%
Shelf Life
24 months (per storage spec)
Storage Temperature
18–22°C
Storage Humidity
55–62% RH
Minimum Order
25 kg per batch
Documentation
COA, Batch Record, Regulatory Package
NACOC Licensed
Ghana’s NACOC Act 1100 and LI 2475 created the first formal pharmaceutical cannabis regulatory framework in the region. HMF Ltd is among the inaugural licence holders.
— Licence granted February 2026 under LI 2475
— Compliance reporting to NACOC on defined schedule
— Full batch-level documentation submitted to regulator
— Security, storage, and chain-of-custody requirements met
Quality Assurance at Every Stage
Quality Assurance & Compliance is not a final checkpoint at HMF Ltd — it is embedded into every stage of production, from the first seed to the final shipment document.
STAGE 01
Genetics & Seed Selection
GACP · NACOC Licence
STAGE 02
Cultivation & Growing
GACP Phase 1 · SOPs Active
STAGE 03
Harvest & Post-Harvest Handling
GACP · ALCOA+ Initiated
STAGE 04
Drying, Curing & Processing
GMP Principles · Process Validation
STAGE 05
Analytical Testing
GMP · Third-Party Tested · COA Issued
STAGE 06
Quality Review & Release
QMS · ALCOA+ · Batch Release
STAGE 07
Packaging, Storage & Shipment
GMP · NACOC Export · ALCOA+ Complete
Data Integrity
All data and documentation at HMF Ltd is maintained to ALCOA+ principles — the gold standard for pharmaceutical data integrity, accepted by all major regulatory authorities.
Every data entry is linked to the person who recorded it, with date and time stamps. No anonymous entries. Complete personnel accountability throughout the production record.
All records are permanently recorded in ink or digital systems. Corrections are made with a single strike-through, initialled and dated — never obscured or overwritten.
Data is recorded at the time of the activity, not reconstructed afterward. Real-time recording is a non-negotiable operational standard enforced through SOPs and training.
The first record of an observation is preserved. Copies and reproductions are marked as such. Original data is never discarded, even when transcription to other systems occurs.
Data reflects the actual observations and measurements made. No selective recording. All results — whether passing or failing — are documented and retained in the permanent batch record.
ALCOA+ compliance means pharmaceutical buyers can rely on HMF documentation during their supplier qualification audits. This is what makes a supply relationship bankable for regulated manufacturers.
Qualified pharmaceutical partners and investors can access our full compliance documentation on request.